The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose

Sun, 11th Jun 2023 14:36

(Sharecast News) - Experts believe that the Bank of England will have to jack up its base rate from 4.5% at present to 5.5% by the end of 2023 in order to tame stubbornly high inflation. It was that prospect that had already resulted in lenders and building societies to raise the cost of fixed-rate mortgages or to pull deals altogether, as HSBC did during the preceding week. Higher rates also have implications for the cost of servicing the country's debts, in turn eliminating the Chancellor's already limited headroom to push through tax cuts before the elections. - The Financial Mail on Sunday

Police looking into accusations of financial misconduct by the Scottish National Party have arrested one of its former leaders, Nicola Sturgeon. Sturgeon was one of three individuals arrested as part of Operation Branchform, which is investigating whether £600,000-worth of donations to the independence campaign had been misspent by the party. - Guardian

Melrose boss Simon Peckham made a staunch defence of the takeover outfit in an interview. The executive said predator firms like his were necessary in markets in order to restructure poorly-run corporations that would otherwise just carry on underperforming. But he derided criticism of the firm as slash and burn merchants. Quite the opposite, Melrose had pumped over £1bn into GKN Aerospace. There were about 12 months of hard work left in order to spruce it up, he added. Indeed, Melrose "lover buying businesses and seeing them get better". - The Financial Mail on Sunday

Jeb Smith - also known as "the most feared man in corporate America" - has UK biotech outfit Abcam in its sights. Starboard Value, the hedge fund run by Smith, has taken a roughly 2% stake in the antibody company. Last year, Abcam shelved plans for a London float, instead pursuing a listing on the US Nasdaq Exchange. In parallel, Abcam's founders, Jonathan Milner, is pushing to be reinstalled as executive chairman. On Monday he will send a note to investors arguing that only under his leadership can the company undo its "sustained financial underperformance and value destruction". A spokesman for the company however said that Milner's claim were without merit. - Sunday Times

More News
20 Apr 2020 10:02

Abcam warns on revenues as Covid-19 hits markets

(Sharecast News) - Life sciences tools provider Abcam warned on full-year revenues on Monday as the Covid-19 pandemic began to take its toll across the group's markets.

Read more
20 Apr 2020 09:41

UK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica

UK BROKER RATINGS SUMMARY: HSBC Downgrades Prudential And Centrica

Read more
14 Apr 2020 16:04

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
9 Apr 2020 18:07

Abacam To Raise GBP110 Million Through Share Issue To Fund Growth

Abacam To Raise GBP110 Million Through Share Issue To Fund Growth

Read more
20 Mar 2020 09:49

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

UK BROKER RATINGS SUMMARY: BHP Gets Upgrades From JPMorgan, Deutsche

Read more
12 Mar 2020 16:05

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
10 Mar 2020 09:38

UK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair

UK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair

Read more
9 Mar 2020 15:48

Abcam 'uncertain' about coronavirus impact as China returns to work

(Sharecast News) - Life science research tools company Abcam reported a 10.8% increase in total revenue increased 10.8% on a reported basis and 8.3% on a constant exchange rate basis in its interim results on Monday, to ?138.2m.

Read more
9 Mar 2020 10:29

UK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses

UK WINNERS & LOSERS SUMMARY: Oil Stocks Sink As Brent Price Collapses

Read more
9 Mar 2020 09:55

ABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue

ABCAM Profit Down In First Half; Expects Coronavirus To Hurt Revenue

Read more
4 Mar 2020 10:26

Abcam acquires Marker Gene Technologies

(Sharecast News) - Life sciences group Abcam extended its assay and labelling capabilities on Wednesday with the acquisition of Marker Gene Technologies for an undisclosed sum.

Read more
4 Mar 2020 10:13

Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares

Abcam Buys US's Marker Gene Technologies, Issues GBP600,000 In Shares

Read more
2 Mar 2020 15:56

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
30 Jan 2020 10:51

Abcam Buys Applied StemCell Gene Editing Platform, Oncology Portfolio

Abcam Buys Applied StemCell Gene Editing Platform, Oncology Portfolio

Read more
28 Jan 2020 18:46

DIRECTOR DEALINGS: Abcam's Milner Secures Over GBP15 Million From Sale

DIRECTOR DEALINGS: Abcam's Milner Secures Over GBP15 Million From Sale

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.